April 23, 2010, Newsletter Issue #68: The Bextra debate
Tip of the Week
One criticism of Bextra and other COX-2 nonsteroidal anti-infalmmatory drugs is that they were sold with a one-size-fits-all dosage for osteoarthritis, unlike traditional NSAIDs that come in a variety of sizes and doses. So, in the words on one critic, "your 90-year old grandmother with arthritic hands will receive the very same, super-strong dosage as Shaquille O'Neal will receive for his arthritic toe."
About LifeTips
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.
